Behavioral stress and antidepressant treatments altered hippocampal expression of Nogo signal-related proteins in rats

J Psychiatr Res. 2024 Feb:170:207-216. doi: 10.1016/j.jpsychires.2023.12.019. Epub 2023 Dec 22.

Abstract

Some immune molecules including neurite outgrowth inhibitor (Nogo) ligands and their receptor(Nogo receptor-1: NgR1)are expressed at the neuronal synaptic sites. Paired immunoglobulin-like receptor B (PirB) is another Nogo receptor that also binds to major histocompatibility complex I and β-amyloid and suppresses dendritic immune cell functions and neuronal plasticity in the central nervous system. Augmenting structural and functional neural plasticity by manipulating the Nogo signaling pathway is a novel promising strategy for treating brain ischemia and degenerative processes such as Alzheimer's disease. In recent decades psychiatric research using experimental animals has focused on the attenuation of neural plasticity by stress loadings and on the enhanced resilience by psychopharmacological treatments. In the present study, we examined possible expressional alterations in Nogo signal-related proteins in the rat hippocampus after behavioral stress loadings and antidepressant treatments. To validate the effectiveness of the procedures, previously reported increase in brain-derived neurotrophic factor (BDNF) by ECS or ketamine administration and decrease of BDNF by stress loadings are also shown in the present study. Significant increases in hippocampal NgR1 and PirB expression were observed following chronic variable stress, and a significant increase in NgR1 expression was observed under a single prolonged stress paradigm. These results indicate a possible contribution of enhanced Nogo signaling to the attenuation of neural plasticity in response to stressful experiences. Additionally, the suppression of hippocampal NgR1 expression using electroconvulsive seizure treatment and administration of subanesthetic dose of ketamine supported the increased neural plasticity induced by the antidepressant treatments.

Keywords: Behavioral stress; Brain-derived neurotrophic factor; Electroconvulsive seizure; Ketamine; Nogo; Paired immunoglobulin-like receptor B.

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Brain-Derived Neurotrophic Factor* / metabolism
  • Hippocampus / metabolism
  • Ketamine*
  • Nogo Receptors / metabolism
  • Rats

Substances

  • Brain-Derived Neurotrophic Factor
  • Ketamine
  • Antidepressive Agents
  • Nogo Receptors